Диссертация (1140821), страница 20
Текст из файла (страница 20)
Патогенез, принципы диагностики и профилактикиосложнений беременности, обусловленных тромбофилией: Дисс. д-ра мед.наук. М., 2004.2.Дедов. И.И., Андреева Е.Н., Карпова Е.А. Синдром поликистозныхяичников этиология, патогенез, диагностика и лечение: практическиерекомендации для врачей. - М.: ООО"Информационные технологии в медицине",2009 -51c.3.Макацария А.Д., Белобородова Е.В., Баймурадова С.М., Бицадзе В.О.Гепергомоцистеинемия и осложнения беременности. М., "Триада - Х", 2007.4.Макацария А.Д., Бицадзе В.О.
и др. Антифосфолипидный синдром -иммунная тромбофилия в акушерстве и гинекологии. М., "Триада - Х", 2013 485с.5.Макацария А.Д., Бицадзе В.О. Тромбофилические состояния вакушерской практике. М.:"РУССО",2001-704с.6.Макацария А.Д., Пшеничникова Е.Б., Пшеничникова Т.Б., БицадзеВ.О. Метаболический синдром и тромбофилия в акушерстве и гинекологии. М.:ООО"Медицинское информационное агенство", 2006. - 480 с.7.Мамот А.П. Патология гемостаза.
Принципы и алгоритмы клинико-лабораторной диагностики. - Спб.: ФормаТ, 2006. - 208 с.8.Матвеева Т.Е., Бицадзе В.О., Баймурадова С.М. и соавт. Основныепринципы ведения беременности у женщин с синдромом потери плода итромбофилией в анамнезе.// Акушерство и генекология. - 2003. - №.4.-с. 26-30.9.Э.К. Айламазяна, В.И.
Кулакова, В.Е. Радзинского, Г.М. Савельевой.Акушерство: национальное руководство - М.: ГЭОТАР- Медиа, 2009.-1200 с.13210.Ageno W., Becattini C., Brighton T. et al. Cardiovascular risk factors andvenous thromboembolism: a meta-analysis. Circulation. 2008; 117: 93-102.11.Aguilera C.M., Ramirez-Tortosa M.C., Mesa M.D., Gil A. Protective effectof monounsaturated and polyunsaturated fatty acids on the development ofcardiovascular disease. Nutr Hosp. 2001; 16: 78-91.12.Alessi MC, Juhan-Vague I. Metabolic syndrome, haemostasis andthrombosis. Thrombosis and Haemostasis 2008 99 995–1000.13.Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Cabezas MC.Postprandial inflammation and endothelial dysfunction. Biochem Soc Trans. 2007;35(Pt 3):466–469.14.Allman-Farinelli M.A.
Obesity and venous thrombosis: a review. SeminThromb Hemost. 2011; 37: 903-907.15.Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K,Favas C, Delgado Alves J, Žigon P, Ambrožič A, Tomšič M, Ruiz-Arruza I, RuizIrastorza G, Bertolaccini ML, Norman GL, Shums Z, Arai J, Murashima A, Tebo AE,Gerosa M, Meroni PL, Rodriguez-Pintó I, Cervera R, Swadzba J, Musial J, Atsumi T.Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for thediagnosis of antiphospholipid syndrome: results of an international multicentre study.Lupus. 2016 Aug 10.
[Epub ahead of print].16.Andersen A.S., Bergholt Т., Berthelsen J.G. Low molecular weight heparin(LMWH) and pregnancy // Thromb Res 2007; 119: Suppl 1: 98—99.17.Andra H. James. Pregnancy-associated thrombosis. Hematology 2009; 277-18.Andra H. James. Venous Thromboembolism in Pregnancy. Arterioscler285.Thromb Vasc Biol. 2009;29:326-331.19.Anfossi G, Russo I & Trovati M. Platelet dysfunction in central obesity.Nutrition, Metabolism, and Cardiovascular Diseases 2009 19 440–449.13320.Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk ofadverse pregnancy outcomes in women who are overweight or obese. BMC PregnancyChildbirth.
2010 Sep 17;10:56. doi: 10.1186/1471-2393-10-56.21.Aubert H., Frere C., Aillaud M.F. et al. Weak and non-independentassociation between plasma TAFI antigen levels and the insulin resistance syndrome. JThromb Haemost. 2003; 1: 791-797.22.Badimon L., Hernandez Vera R., Vilahur G. Atherothrombotic risk inobesity. Hamostaseologie. 2013; 33: 259-68.23.Badimon L., Storey R.F., Vilahur G.
Update on lipids, inflammation andatherothrombosis. Thromb Haemost. 2011; 105 (1): 34-42.24.Banoo Edalat, Farshad Sharifi,Zohre Badamchizadeh, Arash Hossein-Nezhad, Bagher Larijani, Mojde Mirarefin, Hossein Fakhrzadeh. Association ofmetabolic syndrome with inflammatory mediators in women with previous gestationaldiabetes mellitus. J Diabetes Metab Disord. 2013; 12: 8.25.Barker DJ, Osmond C, Kajantie E, Eriksson JG.
Trajectories of growthamong children who have coronary events as adults. N Engl J Med. 2005;353(17):1802–1809.26.Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism,thrombophilia, antithrombotic therapy, and pregnancy: American College of ChestPhysicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest.2008;133:844S-886S.27.Battinelli E.M., Bauer K.A. Thrombophilias in pregnancy. Hematol OncolClin North Am.
2011 Apr; 25 (2): 323-33.28.Bavbek N., Kargili A., Kaftan О. et al. Elevated concentrations of solubleadhesion molecules and large platelets in diabetic patients: are they markers of vasculardisease and diabetic nephropathy? Clin Appl Thromb Hemost. 2007; 13: 391-397.29.Bennett A, Chunilal S. Diagnosis and Management of Deep VeinThrombosis and Pulmonary Embolism in Pregnancy. Semin Thromb Hemost. 2016 Sep22. [Epub ahead of print].13430.Blackburn P, Desprйs JP, Lamarche B, et al.
Postprandial variations ofplasma inflammatory markers in abdominally obese men. Obesity (Silver Spring). 2006;14(10):1747–1754.31.Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am.2008; 37: 635-646.32.Bonetti PO, Lerman LO & Lerman A. Endothelial dysfunction: a marker ofatherosclerotic risk. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 168–175.33.Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome inchildhood: association with birth weight, maternal obesity, and gestational diabetesmellitus.
Pediatrics. 2005 Mar;115(3):290-6.34.Boney CM. Childhood onset and duration of obesity are significant riskfactors for type 2 diabetes in mid-adulthood. Evid Based Nurs. 2012 Apr;15(2):38-9.35.Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetricdiagnosis, management, and controversies. Obstet Gynecol. 2003;101:1333-1344.36.Bremme KA. Haemostatic changes in pregnancy. Best Pract Res ClinHaematol. 2003;16:153-168.37.Brill-Edwards P, Ginsberg JS, Gent M, et al; Recurrence of Clot in ThisPregnancy Study Group.
Safety of withholding heparin in pregnant women with ahistory of venous thromboembolism. N Engl J Med. 2000;343:1439-1444.38.Bruyneel A, Catteau-Jonard S, Decanter C, Clouqueur E, Tomaszewski C,Subtil D, Dewailly D, Robin G. Polycystic ovary syndrome: what are the obstetricalrisks? Gynecol Obstet Fertil. 2014 Feb;42(2):104-11.39.Butte NF, Ellis KJ, Wong WW, Hopkinson JM, Smith EO. Composition ofgestational weight gain impacts maternal fat retention and infant birth weight.
Am JObstet Gynecol. 2003; 189(5):1423–1432.40.Caluwaerts S, Lambin S, van Bree R, Peeters H, Vergote I, Verhaeghe J.Diet-induced obesity in gravid rats engenders early hyperadiposity in the offspring.Metabolism. 2007; 56(10):1431–1438.13541.Casele H, Haney E. Bruising in women undergoing thromboprophylaxis inpregnancy.
Am J Obstet Gynecol. 2006;193:S81.42.Casele H, Haney EI, James A, et al. Bone density changes in women whoreceive thromboprophylaxis in pregnancy. Am J Obstet Gynecol. 2006; 195:1109-1113.43.Castelao JE, Gago-Dominguez M. Risk factors for cardiovascular diseasein women: relationship to lipid peroxidation and oxidative stress.
Med Hypotheses.2008;71(1):39-44.44.Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetaladiposity: a very sensitive marker of abnormal in utero development. Am J ObstetGynecol. 2003; 189(6):1698–1704.45.Chakraborty P, Banerjee S, Saha P, Nandi SS, Sharma S, Goswami SK,Chakravarty B, Kabir SN. Aspirin and low-molecular weight heparin combinationtherapy effectively prevents recurrent miscarriage in hyperhomocysteinemic women.PLoS One.
2013 Sep 5;8(9):e74155.46.Challier JC, Basu S, Bintein T, et al. Obesity in pregnancy stimulatesmacrophage accumulation and inflammation in the placenta. Placenta. 2008; 29(3):274–281.47.Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancyrelated mortalitysurveillance—United States, 991—1999. MMWR Surveill Summ. 2003;52:1-8.48.Chunilal SD, Bates SM. Venous thromboembolism in pregnancy:diagnosis, management and prevention. Thromb Haemost. 2009;101:428-438.49.Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR,Van Pelt RE, Wang H & Eckel RH. The metabolic syndrome. Endocrine Reviews 200829 777–822.50.Corsonello A., Perticone F., Malara A. et al.
Leptin- dependent plateletaggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord.2003; 27: 566-573.13651.Danilenko-Dixon DR, Heit JA, Silverstein MD, et al. Risk factors for deepvein thrombosis and pulmonary embolism during pregnancy or post partum: apopulation- based, case-control study.
Am J Obstet Gynecol. 2001;184:104-110.52.Davi G., Guagnano M.T., Ciabattoni G. et al. Platelet activation in obesewomen: role of inflammation' and oxidant stress. JAMA. 2002; 288: 2008-2014.53.DE Boo HA, Harding JE. The developmental origins of adult disease(Barker) hypothesis. A u s t N Z J Obstet Gynaecol. 2006 Feb;46(l):4-14.54.De Ferranti S., Mozaffarian D. The perfect storm: obesity, adipocytedysfunction, and metabolic consequences. Clin Chem.
2008; 54: 945-955.55.De Pergola G., Pannacciulli N., Coviello M. et al. sP- selectin plasmalevels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis. 2008; 18: 227-232.56.De Stefano V, Martinelli I, Rossi E, et al. The risk of recurrent venousthromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. BrJ Haematol. 2006;135:386-391.57.Despre´s JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E,Rode´s-Cabau J, Bertrand OF & Poirier P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
